Literature DB >> 21475785

Roles of high-mobility group box 1 in murine experimental colitis.

Hiroshi Yamasaki1, Keiichi Mitsuyama, Junya Masuda, Kotaro Kuwaki, Hidetoshi Takedatsu, Gen Sugiyama, Shingo Yamada, Michio Sata.   

Abstract

High-mobility group box 1 (HMGB1) plays a role in inflammatory and immune-mediated diseases. This study investigated the role of HMGB1 in colonic inflammation. Colitis was induced by orally feeding mice 4.5% dextran sulfate sodium (DSS) for up to 7 days. Mice were sacrificed on days 0, 3, 7 and 10, and the colon harvested for the measurement of HMGB1 and pro-inflammatory cytokines. To block HMGB1 induction, an anti-HMGB1 antibody was administered intraperitoneally 2 h before or 3 days after the induction of colitis, and disease severity was assessed by clinical and histological scoring. The colonic levels of tumor necrosis factor-α and interleukin-1β were elevated in relation to disease severity. The level of HMGB1 increased more slowly than that of the cytokines. Immunohistochemical study of the colons showed that the tissues of mice treated with DSS had a higher expression of HMGB1 and its receptor - the receptor for advanced glycation end products - than normal controls, especially in inflammatory infiltrates. The anti-HMGB1 antibody ameliorated tissue damage. In conclusion, HMGB1 is an important mediator of colonic inflammation, and suppression of this protein partially protects against colonic inflammation.

Entities:  

Year:  2009        PMID: 21475785     DOI: 10.3892/mmr_00000056

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

1.  Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation.

Authors:  Xiaorong Zhu; Jeannette S Messer; Yunwei Wang; Fanfei Lin; Candace M Cham; Jonathan Chang; Timothy R Billiar; Michael T Lotze; David L Boone; Eugene B Chang
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 2.  Metallothionein and stress combine to affect multiple organ systems.

Authors:  Michael A Lynes; Juan Hidalgo; Yasmina Manso; Lindsey Devisscher; Debby Laukens; David A Lawrence
Journal:  Cell Stress Chaperones       Date:  2014-03-02       Impact factor: 3.667

3.  Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells.

Authors:  Xiangyu Chen; Dai Fang; Lingyun Li; Liyong Chen; Qirui Li; Feili Gong; Min Fang
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

Review 4.  Role of high-mobility group box 1 protein in inflammatory bowel disease.

Authors:  Zhen Hu; Xiaoyun Wang; Lei Gong; Gaojue Wu; Xiaobin Peng; Xuejun Tang
Journal:  Inflamm Res       Date:  2015-06-16       Impact factor: 4.575

5.  Chronic Intestinal Inflammation Suppresses Brain Activity by Inducing Neuroinflammation in Mice.

Authors:  Jonathon Mitchell; Su Jin Kim; Cody Howe; Seulah Lee; Ji Yun Her; Marisa Patel; Gayoung Kim; Jaewon Lee; Eunok Im; Sang Hoon Rhee
Journal:  Am J Pathol       Date:  2021-10-05       Impact factor: 4.307

Review 6.  Dysfunction of epithelial permeability barrier induced by HMGB1 in 2.5D cultures of human epithelial cells.

Authors:  Takashi Kojima; Yuma Shindo; Takumi Konno; Yuki Kodera; Wataru Arai; Maki Miyakawa; Kizuku Ohwada; Hiroki Tanaka; Mitsuhiro Tsujiwaki; Yuji Sakuma; Shin Kikuchi; Tsuyoshi Ohkuni; Kenichi Takano; Atsushi Watanabe; Takayuki Kohno
Journal:  Tissue Barriers       Date:  2021-09-18

7.  Increase in Epithelial Permeability and Cell Metabolism by High Mobility Group Box 1, Inflammatory Cytokines and TPEN in Caco-2 Cells as a Novel Model of Inflammatory Bowel Disease.

Authors:  Maki Miyakawa; Takumi Konno; Takayuki Kohno; Shin Kikuchi; Hiroki Tanaka; Takashi Kojima
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

Review 8.  Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison?

Authors:  Armando Rojas; Iván Schneider; Cristian Lindner; Ileana Gonzàlez; Miguel Angel Morales
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

9.  Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice.

Authors:  Liping Chen; Junhua Li; Zhenghao Ye; Binghua Sun; Lu Wang; Yu Chen; Jian Han; Meiping Yu; Ying Wang; Qi Zhou; Ursula Seidler; De'an Tian; Fang Xiao
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.